Table 2.
Correlation analysis between CXCL1 expression and clinical characteristics in 212 patients with COAD
| Variable | Negative | positive | χ2 | P-value | ||
|---|---|---|---|---|---|---|
| Gender | 3.720 | 0.054 | ||||
| Male | 20 | 117 | ||||
| Female | 19 | 56 | ||||
| Age (years) | 0.087 | 0.768 | ||||
| ≤65 | 26 | 111 | ||||
| >65 | 13 | 62 | ||||
| CEAa (ng/ml) | 6.671 | 0.010 | ||||
| 1-5 | 28 | 85 | ||||
| >5 | 10 | 83 | ||||
| TNM stage | 5.058 | 0.168 | ||||
| I | 9 | 21 | ||||
| II | 8 | 50 | ||||
| III | 14 | 78 | ||||
| IV | 8 | 24 | ||||
| Location | 0.962 | 0.327 | ||||
| Right | 16 | 86 | ||||
| Left | 23 | 87 | ||||
| Tumor typeb | 0.214 | 0.898 | ||||
| Invasive | 2 | 9 | ||||
| ulcerative | 28 | 125 | ||||
| mass | 9 | 33 | ||||
| Tumor differentiation | 1.401 | 0.496 | ||||
| Well | 3 | 7 | ||||
| Moderately | 27 | 133 | ||||
| poor | 9 | 33 | ||||
| Tumor trombusc | 0.415 | 0.519 | ||||
| No | 33 | 152 | ||||
| Yes | 6 | 20 | ||||
| Tumor sized (cm) | 0.754 | 0.385 | ||||
| <5 | 19 | 71 | ||||
| ≥5 | 19 | 97 | ||||
| Tumor number | <0.001 | 1.000 | ||||
| Single | 38 | 167 | ||||
| Two | 1 | 6 | ||||
| Lymph nodee | 0.086 | 0.769 | ||||
| Negative | 23 | 97 | ||||
| Positive | 16 | 75 | ||||
| Tumor transfer | 0.890 | 0.346 | ||||
| No | 31 | 148 | ||||
| Yes | 8 | 25 | ||||
| Nerve infiltrationf | 0.561 | |||||
| No | 38 | 169 | ||||
| Yes | 1 | 3 | ||||
Notes: a, 6 patients without CEA information; b, 6 patients without general classification information; c, 1 patient without tumor thrombosis information; d, 6 patients without tumor size information; e, 1 patient without lymph node information; f, 1 patient without nerve infiltration information; NA: Not available.